Bombay Oxygen Investments Limited (BOMOXY-B1) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Bombay Oxygen Investments Limited ₹26,782, price ₹17,902, upside +49.6%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Bombay Oxygen Investments Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 25, 2026.
How to read this chart
60‑month range ₹10,062 – ₹37,760 · fair‑value band ₹20,087 – ₹33,478 · the ₹17,902 price screens below the ₹26,782 fair value. Dashed = 300-day average. As of Sep 25, 2026.
Follow Bombay Oxygen Investments in your weekly email
Every Wednesday you see whether Bombay Oxygen Investments is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Bombay Oxygen Investments Limited operates as a non-banking financial institution in India. It invests in mutual funds, other financial instruments, and various listed equities. The company was formerly known as Bombay Oxygen Corporation Limited and changed its name to Bombay Oxygen Investments Limited in October 2018.
Show more
Bombay Oxygen Investments Limited operates as a non-banking financial institution in India. It invests in mutual funds, other financial instruments, and various listed equities. The company was formerly known as Bombay Oxygen Corporation Limited and changed its name to Bombay Oxygen Investments Limited in October 2018. Bombay Oxygen Investments Limited was incorporated in 1960 and is based in Mumbai, India.
Stock analysis
Bombay Oxygen Investments Limited (BOMOXY-B1) currently trades at ₹17,902, while our model-based Fair Value estimate is ₹26,782, implying the stock looks roughly 33.2% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: ₹20,087 (bear) to ₹33,478 (bull), the price of ₹17,902 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Financial Services sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Bombay Oxygen Investments Limited reported revenue of ₹27.1M in FY2026 versus ₹11.7M in FY2022, a compound +23.4%/yr. Reported net income was −₹32.4M in FY2026.
Key figures
Market cap ₹2.7B (≈ $27.9M) · P/E ratio 255.7 · P/S ratio 96.3 · EPS (TTM) ₹70.01 · Dividend yield 0.1% · Net margin −119% · Return on equity −0.7% · Return on assets (EBIT) 5.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 30% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −15% fair-value upside, at 50%, BOMOXY-B1 screens cheaper than that median.
Fair Value models
Bear ₹20,087Fair Value ₹26,782Bull ₹33,478
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹22.94 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.25/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+19.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−21.3%
Start year 2021 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
649.8% (2021) → −147.9% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Compare Bombay Oxygen Investments Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 659 stocks
Beats the industry median on 4/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score46 · Bottom 25%
Fair Value upside+17.9% · Below median
Profitability
Return on assets−0.5% · Bottom 25%
Net margin (TTM)37.6% · Above median
Operating margin (TTM)98.7% · Top 25%
Growth and dividend
Revenue growth16.5% · Above median
Dividend yield (TTM)0.1% · Bottom 25%
Valuation Multiplesvs Asset Management median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Bombay Oxygen Investments Limited (BOMOXY-B1) overvalued or undervalued?
As of Sep 25, 2026, our model estimates a fair value of ₹26,782 versus a price of ₹17,902, about +50% upside (undervalued).
What is the fair value of BOMOXY-B1?
Our model-based fair value for Bombay Oxygen Investments Limited is ₹26,782 (as of Sep 25, 2026), built from audited fundamentals. The current price: ₹17,902.
What is the quality score of BOMOXY-B1?
Bombay Oxygen Investments Limited has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bombay Oxygen Investments Limited (BOMOXY-B1)?
Our model-based price target is the fair value of ₹26,782 (as of Sep 25, 2026) from 2 valuation models. Cautious scenario ₹20,087, optimistic scenario ₹33,478. It is a calculation from audited fundamentals, not an analyst target.
What is the Bombay Oxygen Investments Limited stock forecast for 2026?
Our models put fair value at ₹26,782, about +50% upside versus a price of ₹17,902 (undervalued). Cautious scenario ₹20,087, optimistic scenario ₹33,478. The calculation is refreshed regularly with new filings.
What is the revenue of Bombay Oxygen Investments Limited (BOMOXY-B1)?
Bombay Oxygen Investments Limited reported trailing-twelve-month revenue of about ₹28.0M (latest available figure, as of Sep 25, 2026).
Does Bombay Oxygen Investments Limited pay a dividend?
Bombay Oxygen Investments Limited currently shows a dividend yield of about 0.14% relative to its recent price (as of Sep 25, 2026).
What is the intrinsic value of Bombay Oxygen Investments Limited (BOMOXY-B1)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bombay Oxygen Investments Limited it is ₹26,782 per share (as of Sep 25, 2026), against a price of ₹17,902. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Bombay Oxygen Investments Limited stock overvalued or undervalued in 2026?
As of Sep 25, 2026, BOMOXY-B1 trades below its calculated fair value: price ₹17,902, fair value ₹26,782, a gap of about +50% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BOMOXY-B1?
No. The price is what the market pays today (₹17,902); the fair value is what the company's own numbers justify (₹26,782). For Bombay Oxygen Investments Limited the two are ₹8,880 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bombay Oxygen Investments Limited worth?
The market values Bombay Oxygen Investments Limited at about ₹2.7B (market capitalisation, as of Sep 25, 2026). Per share that is ₹17,902; our models calculate a fair value of ₹26,782 per share.
What do the bullish and bearish scenarios say about BOMOXY-B1?
Our models span a range for Bombay Oxygen Investments Limited: cautious scenario ₹20,087, base ₹26,782, optimistic ₹33,478 per share (as of Sep 25, 2026, price ₹17,902). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BOMOXY-B1?
Bombay Oxygen Investments Limited trades at a price-to-earnings ratio of 255.7 (as of Sep 25, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹26,782 is built from several models across several years. Other multiples: P/B 0.6, P/S 96.1.
How solid is the balance sheet of Bombay Oxygen Investments Limited (BOMOXY-B1)?
Balance-sheet figures for Bombay Oxygen Investments Limited (as of Sep 25, 2026): return on equity −0.7%. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is BOMOXY-B1 from its 52-week high?
Bombay Oxygen Investments Limited trades at ₹17,902, about 30% below its 52-week high of ₹25,400 and at the low of ₹17,902 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹26,782 is for.
Which stocks are comparable to Bombay Oxygen Investments Limited?
From the same area (Financial Services) we also value Blackstone Inc, KKR & Co, Brookfield Corporation, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bombay Oxygen Investments Limited stock attractive at the current price?
The data as of Sep 25, 2026: price ₹17,902, calculated fair value ₹26,782 (+50%), Quality Score 49/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BOMOXY-B1 calculated?
We run Bombay Oxygen Investments Limited through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹26,782, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Bombay Oxygen Investments Limited currently trades 33 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bombay Oxygen Investments Limited (BOMOXY-B1)?
The closing price on Oct 1, 2026 was ₹17,902. Our model-based fair value is ₹26,782, about +50% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bombay Oxygen Investments Limited right now?
The price is below even our cautious bear case (₹20,087). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (49/100) at a price below fair value, the discount is the argument here, not the business quality. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Bombay Oxygen Investments Limited
How large is the market capitalisation of Bombay Oxygen Investments Limited (BOMOXY-B1)?
The market capitalisation of Bombay Oxygen Investments Limited is ₹2.7B (≈ $27.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bombay Oxygen Investments Limited (BOMOXY-B1)?
The price-to-sales ratio of Bombay Oxygen Investments Limited is 96.3 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bombay Oxygen Investments Limited (BOMOXY-B1)?
Earnings per share at Bombay Oxygen Investments Limited are ₹70.01 (price ÷ EPS = P/E 255.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Bombay Oxygen Investments Limited (BOMOXY-B1)?
The dividend yield of Bombay Oxygen Investments Limited is 0.1% (payout 35.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Bombay Oxygen Investments Limited (BOMOXY-B1)?
The net margin of Bombay Oxygen Investments Limited is −119% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bombay Oxygen Investments Limited (BOMOXY-B1)?
The return on equity (ROE) of Bombay Oxygen Investments Limited is −0.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bombay Oxygen Investments Limited (BOMOXY-B1)?
On an EBIT basis the return on assets of Bombay Oxygen Investments Limited is 5.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bombay Oxygen Investments Limited (BOMOXY-B1)?
The operating margin of Bombay Oxygen Investments Limited is 98.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bombay Oxygen Investments Limited (BOMOXY-B1)?
Revenue at Bombay Oxygen Investments Limited is growing +16.5% versus a year earlier (3y avg +28.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bombay Oxygen Investments Limited (BOMOXY-B1)?
Earnings per share at Bombay Oxygen Investments Limited are growing +17.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Bombay Oxygen Investments Limited (BOMOXY-B1) generate?
The free cash flow of Bombay Oxygen Investments Limited is −₹21.8M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Bombay Oxygen Investments Limited in the live analysis
One click puts Bombay Oxygen Investments Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
